/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Rigel Pharmaceuticals Inc. (RIGL) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 9.09\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n 0.50\n\n (+5.82%)\n\n \n\n \n\n \n\n \n\n Volume: 578.96 k\n\n \n\n \n\n\n\n 4:00 PM EST Feb 9, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n
\n \n \n \n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n\n
\n After Hours: \n $ 9.09 \n \n \n \n 0.00\n (0.00%)\n \n \n \n \n Volume: 7.0 k\n \n \n \n4:12 PM EST Feb 9, 2010\n\n \n
\n
\n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
July 21,2009
\n \n
Close: \n 14.75\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
March 06,2009
\n \n
Close: \n 4.19\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
9.09
\n 		\n\n \n \n \n
Change $
\n \n 0.50\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 5.82%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
N/A
\n 		\n \n \n \n\n
Bid Size
0
\n 		\n \n \n \n
Ask
N/A
\n\n 		\n \n \n \n
Ask Size
0
\n
\n \n \n \n
Open
8.62
\n 		\n \n \n \n
High
9.10
\n 		\n\n \n \n \n
Low
8.55
\n 		\n \n\n \n \n
Prev Close
8.59
\n
\n \n\n \n \n
Last Trade
4:00
\n 		\n \n \n \n
Volume
578.96 k
\n 		\n \n \n \n
\n
52 Wk Hi
14.75
\n 		\n\n \n \n \n
52 Wk Low
4.19
\n
\n \n\n \n \n
Market Cap
471.06 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
51,821,947
\n 		\n \n \n \n
EPS (TTM)
-3.24
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
NASDAQ (NSD)
\n
\n
\n
\n
\n
\n \n
Exchange
NSD
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Rigel Pharmaceuticals Inc.\n\n \n\n  (RIGL) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for RIGL\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Feb 05, 2010
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel to Present at BIO CEO & Investor Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 23, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel Receives Milestone Payment from Daiichi Sankyo for Cancer Ligase Target - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 01, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Eleven Rigel Product Candidate Presentations at 2009 ASH Meeting - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 03, 2009
\n\n \n\n\n\n
7:01 AM\n\n\n\n Rigel Announces Third Quarter 2009 Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 02, 2009
\n\n \n\n\n\n
5:43 AM\n\n\n\n Fundamental and Technical Research for LINE, PCAR, RIGL, INTC, NTAP and HERO Posted on BenchmarkJournal.com Today - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Oct 28, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel Announces Presentations at Two Investor Conferences - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Oct 22, 2009
\n\n \n\n\n\n
6:31 AM\n\n\n\n RidgewaterEquity.com Free Fundamental Sector & Market Research on SGEN, PLUG, RIGL, PAET, RPRX and PLAB - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Oct 16, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel to Webcast Analyst Briefing on October 20, 2009 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Sep 17, 2009
\n\n \n\n\n\n
9:19 AM\n\n\n\n Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Sep 16, 2009
\n\n \n\n\n\n
4:00 PM\n\n\n\n Rigel Announces Proposed Offering of 6,000,000 Shares of Common Stock - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Aug 04, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel Announces Second Quarter 2009 Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jul 31, 2009
\n\n \n\n\n\n
11:23 AM\n\n\n\n The Rosen Law Firm, P.A. Encourages Rigel Pharmaceuticals, Inc. Shareholders to Evaluate Their Legal Rights - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jul 23, 2009
\n\n \n\n\n\n
6:01 PM\n\n\n\n R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent - PR Newswire
12:01 PM\n\n\n\n Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jul 09, 2009
\n\n \n\n\n\n
6:00 AM\n\n\n\n Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jul 08, 2009
\n\n \n\n\n\n
9:00 PM\n\n\n\n Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jun 10, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel to Present at Jefferies Healthcare Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jun 01, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, May 13, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Rigel to Present at JMP Securities Research Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, May 05, 2009
\n\n \n\n\n\n
7:01 AM\n\n\n\n Rigel Announces First Quarter 2009 Financial Results - PR Newswire
\n\n More News for RIGL >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");